Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

The patient with lupus and Degos' disease showed significant improvement with treatment.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Early recognition and treatment of severe SLE symptoms can improve outcomes.

Early detection and aggressive treatment of severe lung complications in lupus are crucial to improve survival.

Lupus can cause a type of hair loss that doesn't scar, due to inflammation.

Children with systemic lupus erythematosus have different skin symptoms than adults.

A girl with lupus had unusually long and thick eyelashes, a rare symptom of her condition.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Pincer nails are rare in lupus patients and may be managed conservatively.

Skin symptoms in lupus help diagnose and manage the disease early.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

A patient with lupus experienced a condition where their immune cells became overactive.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Autoimmune diseases like lupus, dermatomyositis, and scleroderma can cause hair loss and other hair problems, and treatments for these diseases might also affect hair.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.